SARS-CoV-2,使

Leda Bassit1, Heather B Bowers1, Morgan Greenleaf2

  • 1The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, GA, USA; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University, Atlanta, GA, USA.

STAR protocols
|June 21, 2024
PubMed
概括

这项研究提供了一个协议,用于从临床样本中创建SARS-CoV-2变种测试面板. 这确保了诊断测试可以检测新的严重急性呼吸综合征冠状病毒2变体.